Siren Biotechnology

$28M raised from leading VCs including Founders Fund, Lux Capital, and more
Fighting the world’s second deadliest disease, cancer, with AAV immuno-gene therapy
Led by expert doctors and scientists from Stanford, UCSF, Duke, Mount Sinai, and Roche
2025 Start Up of The Year winner at Phacilitate Advanced Therapies Week
$4M in competitive grant awards from the California Institute for Regenerative Medicine (CIRM)
Targeting clinical trials in 2026, a critical step toward FDA approval and commercialization
The global brain tumor therapeutics market is a $3.2B market
CEO featured in The Wall Street Journal, The Economist, WIRED, MIT Tech Review, and Boston Globe

Tier 1 VC-Backed
Raised $250K or more from a top-tier venture firm, Dr. Nicole K. Paulk, PhDCEO, Founder, and PresidentAward-winning biotech executive. Deep patent portfolio. Scientific Advisory Board member for renowned companies like Sarepta, Astellas & Dyno Tx. Former gene therapy faculty at UCSF. Oregon Health & Science University PhD. Stanford Postdoctoral Fellow., Dr. Nathalie Clément, PhDSVP, Vector DevelopmentGene therapy pioneer for over 25 years. Drug manufacturing expert. Pivotal role at Powell Gene Therapy Center at the University of Florida, has gotten 10 AAV INDs approved. Led the Vector Core at Mount Sinai. Universite Libre de Bruxelles BS and PhD., Dr. Edward Schnipper, MDLead, Clinical DevelopmentExpert in clinical trial design for innovative cancer therapies. Previously President & CEO of Cellgate, EVP & Chief Medical Officer at Novacea, and VP of Clinical Development at ALZA Corporation. Pivotal role in securing FDA approval for multiple drugs., Lauren Kelly, MSDirector, Preclinical ResearchPharmaceutical trailblazer. Veteran in drug development for multiple disease indications and biologic modalities. Expert in animal models of neuro-oncology. California Polytechnic State University San Luis Obispo BS & MS., Dr. Akela Kuwahara, PhDChief of Staff and Director, Corporate StrategyInnovative disruptor. Ex-Gordian Biotech; led next-gen sequencing for longevity gene therapy screening. Smithsonian Institute researcher. Fulbright Scholar. Stanford Research Fellow. UCSF PhD.